Sudeep Gill

Dr. Sudeep S. Gill, MD MSc FRCPC is a Canadian geriatrician and health services researcher based in Kingston, Ontario.

Career and Affiliations

Queen's University

Gill is an associate professor in the Division of Geriatric Medicine, with cross-appointment in the Department of Public Health Sciences in the Department of Medicine at Queen's University.1)

He he has been a member of Senate Advisory Research Committee (2009-2012), a member of the AHSC AFP Innovation Fund grant application review committee, and a member of the Department of Medicine Promotions Committee.

ICES

Gill is a senior adjunct scientist at the Institute for Clinical Evaluative Sciences (ICES).2)

Clinical Work

Gill works in Specialized Geriatrics services at Providence Care (inpatient geriatric rehabilitation and outpatient geriatric medicine clinics) and Kingston General Hospital (geriatrics consult service).3) He previously served as Chair of the Providence Care Pharmacy and Therapeutics Committee.

Both facilities raise money through the University Hospitals Kingston Foundation, including from a variety of pharmaceutical companies.4)

Government of Ontario

Gill has been a member of the Committee to Evaluate Drugs (CED), an advisory committee to the Ontario Ministry of Health and Long-Term Care on decisions about medications included on the province’s publicly funded formulary.

Ontario COVID-19 Science Advisory Table

Gill is a member of the Congregate Care Setting Working Group of the Ontario COVID-19 Science Advisory Table.5)

Research

Funding

1)
Gill | Department of Medicine | School of Medicine. Queen’s University. Retrieved May 5, 2022, from https://archive.ph/zYmh6
2)
Sudeep Gill. Institutes for Clinical Evaluative Sciences. Retrieved May 6, 2022, from https://www.ices.on.ca/About-ICES/ICES-Scientists/G/Sudeep-Gill
3)
Doctor Gill, Sudeep S - Geriatric Medicine. (2021, August 13). South East Local Health Integration Network. https://archive.ph/iwdoG
4)
Recognizing Your Contribution. Kingston University Hospital Foundation. Retrieved May 4, 2022, from https://web.archive.org/web/20220504073124/https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution
5)
About Us. Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/
6)
Vozoris, N. T., Pequeno, P., Li, P., Austin, P. C., Stephenson, A. L., O’Donnell, D. E., Gill, S. S., Gershon, A. S., & Rochon, P. A. (2021). Morbidity and mortality associated with prescription cannabinoid drug use in COPD. Thorax, 76(1), 29–36. https://doi.org/10.1136/thoraxjnl-2020-215346
7)
About Us. (2016, December 10). Canadian Lung Association. https://archive.ph/XNGx1
9)
2019/2020 Annual Report. Wayback Machine; Canadian Lung Association. Retrieved May 5, 2022, from https://web.archive.org/web/20220505235859/https://www.lung.ca/sites/default/files/LungAssociation_AnnualReport_2019_2020_EN.pdf
12)
2014/2015 Annual Report. Canadian Lung Association. Retrieved May 6, 2022, from https://web.archive.org/web/20160413195706/http://www.lung.ca/file/1172/download?token=B8JBiFLw
Print/export